Plain-English translation of NCT07787052 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting tumor tissue and lymph nodes from people with gastric cancer who are being treated with standard chemotherapy. Researchers will use advanced laboratory techniques to study how your cancer cells respond to this treatment, which may help doctors better understand and treat gastric cancer in the future.
Gastric cancer is challenging to treat, and doctors need better ways to predict which patients will respond well to chemotherapy. By studying tumor samples from patients like you, researchers hope to discover new patterns that could help personalize treatment plans and improve outcomes for future patients.
You likely qualify if…
You likely don't qualify if…
Your participation is based on tissue samples that are already being collected as part of your standard cancer care — no extra visits or procedures are required beyond your normal treatment. The tumor tissue removed during your surgery and lymph nodes collected as part of standard care will be used for laboratory analysis. Researchers will study these samples using advanced techniques to understand how your individual cancer responded to chemotherapy.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
France
Enrollment target
~60 participants
Started
September 2024
Primary completion
September 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Clelia Coutzac, MD,PhD
Centre Leon Berard
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.